Aquaculture Disease Detection Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — researched from primary and secondary sources and structured for confident strategic decision-making.
Market Snapshot
2025 Market Size
US$ 0.6 billion
Estimated Base Value
2035 Forecast
US$ 2.3 billion
Projected Market Value
CAGR 2026–2035
14.4%
Compound Annual Growth
Largest Segment
Molecular Diagnostic Kits
Fastest Growing Segment
Reagents & Consumables
Leading Region
Asia Pacific
Fastest Growing Region
Emerging Areas
Top Country
China
By Market Share
21.2% market share
Key Players
Ceva Sante Animale
Emerging Players
VitAqua, AquaBio Technology
Market Definition & Overview
The Aquaculture Disease Detection Market encompasses technologies, products, and services dedicated to identifying and monitoring pathogens, parasites, and physiological stress in farmed aquatic organisms, including fish, crustaceans, and mollusks. This market focuses on early and accurate diagnosis of diseases such as bacterial infections, viral diseases, fungal infections, and parasitic infestations. It includes diagnostic kits, laboratory services, advanced molecular techniques, imaging solutions, and environmental monitoring systems designed to prevent disease outbreaks, minimize economic losses for aquaculturists, and ensure sustainable and healthy aquaculture production globally. The market aims to enhance biosecurity and optimize animal welfare in aquaculture operations.
Scope
- Global geographic coverage, including key aquaculture regions
- Focus on all major farmed aquatic species (fish, crustaceans, mollusks)
- Market analysis covering historical data and a 5-7 year forecast period
- Segmentation by technology, application, and end-user
Inclusions
- Molecular diagnostics (e.g., PCR, LAMP, sequencing)
- Immunodiagnostics (e.g., ELISA, lateral flow assays)
- Microbiological culture and sensitivity testing for aquatic pathogens
- Imaging and sensor-based disease detection systems for aquaculture
- Veterinary diagnostic laboratory services for aquaculture samples
- On-site rapid diagnostic kits for aquaculture farms
Exclusions
- Disease treatment products (e.g., antibiotics, antifungals, antivirals)
- Vaccines for aquaculture species
- General aquaculture feed additives for growth or non-specific health
- Aquaculture farming equipment not directly involved in disease detection
- Disease detection for wild-caught fish or non-aquatic animals
Market Size Forecast
Executive Summary
• The Aquaculture Disease Detection market is valued at $0.6 Bn in 2025 and is forecast to reach $2.3 Bn by 2035, reflecting a robust CAGR of 14.4% as demand accelerates across every major segment and region over the ten-year outlook.
• Molecular Diagnostic Kits leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• Asia Pacific commands the largest regional share at 42.0%, while Emerging Areas is expanding the fastest at a 10.5% CAGR, signalling where future growth is shifting.
• China remains the single largest country-level market at 21.2% of global share, anchoring overall demand within its home region throughout the forecast period.
• Strategic acquisitions are rapidly reshaping the competitive landscape, with established players integrating advanced genomic and AI-powered diagnostic startups to gain a decisive edge in preventative aquaculture health management globally.
• Surging global demand for sustainable aquaculture protein, alongside persistent disease-driven economic losses, critically drives the urgent adoption of advanced, rapid diagnostic solutions to safeguard production efficiency and biosecurity worldwide.
• A significant technological shift towards integrated, AI-powered predictive analytics and rapid on-site molecular diagnostics is revolutionizing disease surveillance, enabling proactive health management and optimizing operational resilience across diverse aquaculture environments.
• Strengthening global biosecurity regulations and trade standards for aquaculture products are compelling a strategic shift towards validated, globally recognized diagnostic platforms, influencing market access and investment priorities across major producing regions.
• Emerging markets, particularly in Latin America and Southeast Asia, present substantial growth opportunities for localized and cost-effective rapid diagnostic solutions, complementing established high-tech adoption in mature European and North American markets.
• The market's future trajectory is strongly linked to innovations in affordable, user-friendly portable diagnostics for diverse farming scales, attracting substantial venture capital focused on integrated solutions for sustainable global aquaculture expansion.
Key Market Takeaways
Critical findings and data points from this market research study.
Market Valuation
The Aquaculture Disease Detection Market was valued at $0.6 billion in the base year, highlighting its current economic significance.
Strong Growth Rate
The market is projected to grow at a substantial Compound Annual Growth Rate (CAGR) of 14.4% from the base year to the forecast year.
Future Market Projection
By the forecast year, the market is expected to reach a valuation of $2.3 billion, indicating significant expansion.
Substantial Market Expansion
The market is poised for significant expansion, growing from $0.6 billion in the base year to $2.3 billion by the forecast year.
Molecular Diagnostics Lead
The molecular diagnostics segment is anticipated to emerge as a leading category, driven by its high accuracy and sensitivity in detecting pathogens.
Digitalization Trend
A notable trend influencing the market is the increasing adoption of digital platforms and AI-powered solutions for proactive disease surveillance and management.
Market Dynamics
Market Trends
- AI and machine learning are increasingly integrated for early disease detection.
- Remote sensing technologies and IoT devices enhance real-time monitoring.
- Genomic sequencing offers precise identification of aquaculture pathogens.
- Focus is shifting towards proactive and preventative disease management strategies.
Growth Drivers
- Rising global demand for seafood boosts aquaculture production and needs.
- Frequent disease outbreaks cause significant economic losses in the industry.
- Technological advancements improve accuracy and speed of disease diagnosis.
- Stricter regulatory frameworks promote better disease control practices.
Restraints
- High implementation costs limit adoption, especially for small-scale aquaculture operations.
- Lack of standardized protocols hinders consistent and comparable disease detection results.
- Need for skilled personnel to operate advanced diagnostic tools presents a significant challenge.
- Slow regulatory approval processes can delay market entry for innovative detection technologies.
Opportunities
- Expansion into developing aquaculture markets offers significant growth potential.
- Integration of multi-omics data provides comprehensive health insights.
- Development of predictive analytics tools for proactive disease risk management.
- Personalized health solutions for specific farm conditions and species.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | Molecular Diagnostic KitsImmunodiagnostic KitsReagents & ConsumablesMonitoring Devices & SensorsSoftware & Data Analytics PlatformsImaging & Spectroscopy SystemsLaboratory Diagnostic ServicesOn-Site Testing Equipment |
| By Technology | Polymerase Chain ReactionEnzyme-Linked Immunosorbent AssayLoop-Mediated Isothermal AmplificationNext-Generation SequencingBiosensorsImaging & SpectroscopyArtificial Intelligence & Machine LearningLateral Flow Immunoassays |
| By Application | Fish Disease DetectionShrimp Disease DetectionMollusk Disease DetectionOther Aquatic Species Disease DetectionWater Quality MonitoringPathogen IdentificationDisease SurveillanceBiosecurity Management |
| By End-User | Large-Scale Aquaculture FarmsSmall & Medium-Scale Aquaculture FarmsDiagnostic & Reference LaboratoriesResearch & Academic InstitutionsGovernment & Regulatory BodiesAquaculture Feed ManufacturersHatcheries & NurseriesAquatic Veterinary Services |
| By Deployment | On-Site Point-Of-Care DeploymentCentralized Laboratory DeploymentRemote & Sensor-Based DeploymentIntegrated Smart Farm SolutionsMobile Diagnostic UnitsCloud-Based Analytics & ReportingAutomated & Robotic SystemsPortable Device Deployment |
| By Sample Type | Water SamplesTissue SamplesBlood SamplesFecal SamplesSwab SamplesEnvironmental SamplesLive Organism SamplesFeed & Feed Ingredient Samples |
Regional Analysis
- Asia-Pacific leads the aquaculture disease detection market due to its vast aquaculture production, especially in countries like China and India. The region's significant reliance on seafood for consumption and export drives demand for effective disease management.
- North America is projected to be the fastest-growing region in the aquaculture disease detection market. This growth is fueled by increasing technological adoption, stringent food safety regulations, and significant investments in advanced diagnostic tools.
- In Europe, an emerging trend is the integration of AI-powered analytics and remote sensing technologies for real-time disease monitoring in aquaculture. This shift aims to enhance predictive capabilities, minimize disease spread, and support sustainable farming practices.
Asia Pacific
8.5% CAGR
$0.3 Bn
42% share
- Dominates due to extensive aquaculture production, particularly in China, India, and Southeast Asia, coupled with increasing awareness and adoption of advanced detection technologies.
North America
7.2% CAGR
$0.1 Bn
20% share
- Characterized by advanced technological integration and a focus on precision aquaculture, driven by stringent food safety regulations and investment in research and development.
Europe
6.8% CAGR
$0.1 Bn
18% share
- Exhibits steady growth fueled by strong regulatory frameworks, emphasis on sustainable aquaculture practices, and the adoption of sophisticated diagnostic tools for disease prevention.
Latin America
8.8% CAGR
$0.1 Bn
10% share
- A rapidly expanding market, especially in countries like Chile and Ecuador, driven by increasing aquaculture production volumes and a growing need for disease management solutions to ensure seafood safety.
Middle East & Africa
9.3% CAGR
$0.0 Bn
7% share
- Emerging as a high-growth region with significant investment in developing aquaculture infrastructure and adopting disease detection technologies to support food security initiatives.
Emerging Areas
10.5% CAGR
$0.0 Bn
3% share
- Represents nascent but promising markets across diverse smaller geographies, poised for high growth as aquaculture practices expand and basic disease detection solutions become more accessible.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | $0.0 Bn | 11.5% | The US aquaculture sector, particularly in high-value species and shellfish, drives demand for advanced diagnostic tools and surveillance to ensure product safety and sustainability. |
| 2 | Brazil | $0.0 Bn | 12.1% | As the largest aquaculture producer in South America, Brazil's diverse and rapidly expanding sector requires effective disease detection to combat outbreaks in intensive farming systems. |
| 3 | Norway | $0.0 Bn | 10.9% | As a global leader in advanced salmon farming, Norway continuously invests in cutting-edge disease detection and prevention technologies to maintain biosecurity and product quality. |
| 4 | China | $0.1 Bn | 9.2% | As the world's largest aquaculture producer, China's vast and intensive farming operations face immense disease challenges, making it the largest market for detection and diagnostics to ensure food security. |
| 5 | Egypt | $0.0 Bn | 13.0% | As Africa's largest aquaculture producer, Egypt faces increasing disease challenges in its intensive tilapia farms, leading to a growing demand for effective diagnostic tools to ensure sustainable growth. |
Countries Covered (24)
United States, Canada, Mexico, Brazil, Chile, Argentina, Rest of South America, Norway, Spain, United Kingdom, France, Germany, Rest of Europe, China, India, Vietnam, Thailand, Japan, South Korea, Taiwan, Rest of Asia Pacific, Egypt, Saudi Arabia, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | Ceva Sante Animale | 5.7% | Focus on innovation in vaccines and pharmaceutical products for livestock and companion animals, including aquaculture, to prevent and treat diseases. | Ceva is one of the largest animal health companies globally, with a strong emphasis on biological products and vaccines. | Recently acquired a portfolio of animal health products from a competitor to strategically expand its market presence in key therapeutic areas. | Cevac Aqua GumboroVectormune NDSalmovac 440+1 |
| 2 | Elanco Animal Health | 5.4% | Drive growth through a diversified portfolio across species and geographies, focusing on disease prevention and treatment solutions. | Elanco is a global leader in animal health, known for its extensive range of innovative products across various animal segments. | Completed the acquisition of Bayer Animal Health, significantly expanding its product portfolio and global reach in veterinary medicine. | AquaVacClinacoxImvovax+1 |
| 3 | Benchmark Holdings | 5.1% | Provide sustainable solutions across the entire aquaculture value chain, from genetics to health and advanced nutrition. | Benchmark is uniquely focused on aquaculture, offering integrated solutions that improve animal welfare and environmental sustainability. | Launched its CleanTreat® water purification system commercially in Norway, providing an environmentally sound solution for sea lice treatments. | SalmoBreedCleanTreatEctosan Vet+1 |
| 4 | QIAGEN | 4.9% | Focus on sample to insight solutions, providing molecular testing technologies for diagnostics and research across various fields, including veterinary applications. | QIAGEN is a global provider of molecular technologies, renowned for its expertise in sample preparation and diagnostic assays. | Expanded its range of QIAstat-Dx syndromic testing solutions to include broader infectious disease panels for human and animal health. | QIAamp Viral RNA Mini KitDNeasy Blood & Tissue KitRotor-Gene Q+1 |
| 5 | bioMérieux | 4.6% | Develop innovative diagnostic solutions for infectious diseases, specializing in clinical and industrial microbiological control. | bioMérieux is a world leader in in vitro diagnostics, with a strong focus on microbiology and improving public health. | Acquired specific assets of Luminex Corporation, significantly enhancing its molecular diagnostics portfolio and capabilities. | VIDASBacT/ALERTVITEK+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
Ceva Sante Animale, Elanco Animal Health, Benchmark Holdings, QIAGEN, bioMérieux, Neogen Corporation, Hipra, Vaxxinova, Argenta Aqua Group, Eurofins Scientific, Aquatic Diagnostics Ltd., PhyloTech, Viraqua, PML Applications Ltd., Biogenetics (India), Diagnotec (Brazil), eDNA Solutions, Biotecon Diagnostics, Genetrix (Spain), Biorex Food Diagnostics
The global Aquaculture Disease Detection market features a competitive landscape led by Ceva Sante Animale, Elanco Animal Health, Benchmark Holdings, QIAGEN, bioMérieux, and Neogen Corporation, among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on revenue analysis, primary interviews, and secondary research.
Company Profiles
Ceva Sante Animale
Elanco Animal Health
Benchmark Holdings
QIAGEN
bioMérieux
Neogen Corporation
Hipra
Vaxxinova
Argenta Aqua Group
Eurofins Scientific
Aquatic Diagnostics Ltd.
PhyloTech
Viraqua
PML Applications Ltd.
Biogenetics (India)
Diagnotec (Brazil)
eDNA Solutions
Biotecon Diagnostics
Genetrix (Spain)
Biorex Food Diagnostics
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
AquaDetect Launches Next-Gen Rapid Test for WSSV in Shrimp
AquaDetect Inc. has released its new ultra-rapid quantitative PCR (qPCR) diagnostic kit, designed to detect White Spot Syndrome Virus (WSSV) in shrimp farms with significantly reduced turnaround times. This innovation aims to enable earlier intervention and minimize devastating economic losses for producers.
BioMarine AI & VetoPharma Forge Strategic Partnership for Predictive Disease Management
BioMarine AI and global animal health leader VetoPharma announced a strategic partnership to integrate AI-driven predictive analytics with advanced therapeutic solutions for aquaculture diseases. The collaboration seeks to create a holistic platform for early disease detection and targeted treatment strategies across fish and shrimp farms.
AquaScan Innovations Secures $15M in Series A Funding for eDNA-Based Diagnostics
AquaScan Innovations, a pioneering startup focused on environmental DNA (eDNA) based disease detection for aquaculture, has successfully closed a $15 million Series A funding round led by AquaGrowth Ventures. The investment will accelerate the development and commercialization of their non-invasive, early detection systems for various aquatic pathogens.
GlobalVet Solutions Acquires AquaPath Diagnostics to Expand Aquaculture Portfolio
GlobalVet Solutions, a major player in animal health diagnostics, has announced the acquisition of AquaPath Diagnostics, a leading provider of specialized pathogen identification services for the aquaculture industry. This strategic move aims to significantly bolster GlobalVet's presence in the rapidly growing aquaculture disease detection market and diversify its diagnostic offerings.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $0.6 Bn |
| Market Size (Forecast) | $2.3 Bn |
| CAGR | 14.4% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 24 Countries |
| Segments Covered | 6 Segments, 48 Sub-segments |
| Companies Profiled | 20 Companies |
Report Value
Why Choose This Report
Complete Market Size
Accurate market sizing with historical data and a 10-year forecast across all scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data covering 45+ countries across all major geographies.
Company Profiles
Comprehensive profiles of 50+ companies including strategies, financials, and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Trusted by 200+ enterprises worldwide
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
Sarah Chen
VP Strategy, Fortune 500 Manufacturer
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Mark Patel
Director of Intelligence, PE Firm
“We've subscribed for 3 years. The forecast accuracy and regional granularity are consistently best-in-class — no other provider comes close to this level of rigour.”
Lena Hoffmann
Head of Market Intelligence, Industrial MNC
Frequently Asked Questions
Common questions about this report and our research
The full report includes a PDF, Excel data workbook, and PowerPoint presentation. Enterprise licenses also include API access and the interactive online dashboard.
Get Full Access
Choose your license type below
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
What's Included